VEGFA and Hepatic fibrosis: This is likely the reason why we had contrasting results connected with VEGF-A but it could also imply that the concentration of this biomarker may not be relevant if HCV is taken as an independent risk factor for CVD and that it has more to do with the progression of liver fibrosis.